Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome p450 inhibitors

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

related to degree

  • Takeuchi, Cindy, Ph.D. in Chemistry, Scripps Research 2000 - 2005

authors

  • Granville, D. J.
  • Tashakkor, B.
  • Takeuchi, Cindy
  • Gustafsson, A. B.
  • Huang, C. Q.
  • Sayen, M. R.
  • Wentworth Jr., Paul
  • Yeager, Mark
  • Gottlieb, R. A.

publication date

  • February 2004

journal

  • Proceedings of the National Academy of Sciences of the United States of America  Journal

abstract

  • Ischemia and reperfusion both contribute to tissue damage after myocardial infarction. Although many drugs have been shown to reduce infarct size when administered before ischemia, few have been shown to be effective when administered at reperfusion. Moreover, although it is generally accepted that a burst of reactive oxygen species (ROS) occurs at the onset of reperfusion and contributes to tissue damage, the source of ROS and the mechanism of injury is unclear. We now report the finding that chloramphenicol administered at reperfusion reduced infarct size by 60% in a Langendorff isolated perfused rat heart model, and that ROS production was also substantially reduced. Chloramphenicol is an inhibitor of mitochondrial protein synthesis and is also an inhibitor of a subset of cytochrome P450 monooxygenases (CYPs). We could not detect any effect on mitochondrial encoded proteins or mitochondrial respiration in chloramphenicol-perfused hearts, and hypothesized that the effect was caused by inhibition of CYPs. We tested additional CYP inhibitors and found that cimetidine and sulfaphenazole, two CYP inhibitors that have no effect on mitochondrial protein synthesis, were also able to reduce creatine kinase release and infarct size in the Langendorff model. We also showed that chloramphenicol reduced infarct size in an open chest rabbit model of regional ischemia. Taken together, these findings implicate CYPs in myocardial ischemia/reperfusion injury.

subject areas

  • Animals
  • Chloramphenicol
  • Cimetidine
  • Creatine Kinase
  • Cytochrome P-450 Enzyme Inhibitors
  • Cytochrome P-450 Enzyme System
  • Enzyme Inhibitors
  • Mitochondria, Heart
  • Myocardial Ischemia
  • Myocardial Reperfusion Injury
  • Rabbits
  • Rats
  • Reactive Oxygen Species
  • Sulfaphenazole
scroll to property group menus

Identity

PubMed Central ID

  • PMC337051

International Standard Serial Number (ISSN)

  • 0027-8424

Digital Object Identifier (DOI)

  • 10.1073/pnas.0308185100

PubMed ID

  • 14734800
scroll to property group menus

Additional Document Info

start page

  • 1321

end page

  • 1326

volume

  • 101

issue

  • 5

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support